Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More info should have been included in the 8-K Filing (?)

Look at the SP and it's to make an argument that we could not use some protection right now - millions are being lost.

 

One only loses if one sells. There are those who purchased at over $1.00. I hope that it was after thorough DD and not the fear of missing a quick profit. So, if after the DD those purchasers determined that $1.00 was a viable price at which to buy, what has changed for the worse to make that valuation less? In my humble opinion, the viable buying price has increased as a result of the settlement in Marshall and all the additional licensees.

The PR has been badly handled, but how does that detract from the underlying fundamentals of a company with no debt and a growing cash pile?

 

 

Be well

Share
New Message
Please login to post a reply